Navigation Links
NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
Date:7/22/2009

Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

"With the emergence of the 2009 H1N1 influenza virus, we have undertaken a collaborative and efficient process of vaccine development that is proceeding in stepwise fashion," says NIAID Director Anthony S. Fauci, M.D.

After the isolation and characterization of the virus, the U. S. Centers for Disease Control and Prevention generated and distributed a 2009 H1N1 seed virus to vaccine manufacturers for the development of vaccine pilot lots for testing in clinical trials.

"Now, NIAID will use our longstanding vaccine clinical trials infrastructurethe Vaccine and Treatment Evaluation Unitsto help quickly evaluate these pilot lots to determine whether the vaccines are safe and to assess their ability to induce protective immune responses," says Dr. Fauci. "These data will be factored into the decision about how and if to implement a 2009 H1N1 flu immunization program this fall."

Initial studies will look at whether one or two 15 microgram doses of H1N1 vaccine are needed to induce a potentially protective immune response in healthy adult volunteers (aged 18 to 64 years old) and elderly people (aged 65 and older). Researchers also will assess whether one or two 30 microgram doses are needed. The doses will be given 21 days apart, testing two manufacturers' vaccines (Sanofi Pasteur and CSL Biotherapies). If early information from those trials indicates that these vaccines are safe, similar trials in healthy children (aged 6 months to 17 years old) will begin.

A concurrent set of trials will look at the safety and immune response in healthy adult and eld
'/>"/>

Contact: Anne A. Oplinger
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
2. J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases
3. NIAID and Chinese officials sign agreement to foster TB research in Chinas Henan province
4. NIAID honors AIDS activist Martin Delaney
5. NIAID media availability: Seizures following parasitic infection associated with brain swelling
6. NIAID awards contracts to search for protein markers of disease
7. NIAID creates HIV vaccine discovery branch
8. NIAID to advance B-cell approach to HIV vaccines
9. NIAID describes research priorities to fight drug-resistant tuberculosis
10. NIAID to convene HIV Vaccine Summit
11. NIAID scientists identify new cellular receptor for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 04, 2015 When people talk about venues ... artists spread across numerous genres, the Houston Rodeo ... Each night during the annual livestock show and rodeo, one ... the other activities being held at the event. The 2015 ... performers that will try and get the festival its largest ...
(Date:3/4/2015)... FDA’s New Inspection Approach:, What Your Inspector ... 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... hours of an inspection whether a manufacturer’s in trouble ... list, they’ll merely ask for reassurance that they know ... “bad” list, the manufacturer must get ready to convince ...
(Date:3/4/2015)... With the growing influence of movies, television, video games ... young adults, combined with the increasingly frantic lifestyle of modern ... keep up with what kids are into these days. It ... a daily basis. , The same is also true for ... used to discreetly talk about them, are constantly changing. These ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Vancouver ... recently received two awards in the prestigious Vancouver ... on February 27, 2015. The company secured third ... place in the “Best Registered Massage Therapist” category. ... community newspapers in Canada, The Vancouver Courier is ...
(Date:3/4/2015)... State officials have awarded $82,500 to ... Public Health at Georgia State University, to support the ... Georgia’s Division of Family and Children Services (DFCS) as ... Center. , The 1-800-CHILDREN Helpline is a top ... referral services that promote the wellbeing of children while ...
Breaking Medicine News(10 mins):Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:State Funds Child Abuse Helpline Housed At Georgia State 2
... HCD Research and Muhlenberg ... a series of national studies to obtain physicians, ... care reform plan.(Logo: http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO ) , ... other forms of communications relating to health care ...
... their predecessors, researchers say , , THURSDAY, March 12 (HealthDay News) ... compared with their counterparts 10 or 20 years ago, researchers ... are being hospitalized for heart attacks now than people their ... could place a big burden on cardiac care wards nationwide. ...
... Anticipate Long-term Relationship with Esteemed Company , PASADENA, Calif., ... Co. will serve as the Awards Sponsor of the ... event will be held on March 22, 2009. ... men,s and women,s marathon with a commemorative gift. ...
... Federal Stimulus Law Should Include Care Management Software ... InfrastructureAUBURN, Calif., March 12 TCS ... development of medical management software applications, supports the ... economic stimulus package, referred to as the American ...
... aren,t listed on labels; manufacturers say products are safe ... and child-care products contain the chemicals formaldehyde and 1,4-dioxane, ... various skin conditions, a new report contends. , ... bubble bath, shampoo and other common products, according to ...
... Better LIFE Wellness Classes to Help Raise Kidney Health ... one of the nation,s first and largest providers of ... research, today announced it will do its part to ... Disease (CKD), by offering free Better LIFE wellness classes ...
Cached Medicine News:Health News:HCD Research and Muhlenberg College Will Use an Index to Monitor Physicians' and Consumers' Perceptions of Health Care Reform 2Health News:Aging Baby Boomers May Swamp Cardiac Care 2Health News:Aging Baby Boomers May Swamp Cardiac Care 3Health News:Pasadena Marathon Presented By Kaiser Permanente Hails Partnership With Tiffany & Co. 2Health News:TCS Healthcare Technologies Offers Health IT Solutions That Support Health Care Reform 2Health News:TCS Healthcare Technologies Offers Health IT Solutions That Support Health Care Reform 3Health News:Children's Bath Products Contain Contaminants 2Health News:Children's Bath Products Contain Contaminants 3Health News:Satellite Healthcare Celebrates World Kidney Day and National Kidney Month 2Health News:Satellite Healthcare Celebrates World Kidney Day and National Kidney Month 3
(Date:3/4/2015)... Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), ... today announced its financial results for the fourth quarter ... 2014 Financial Highlights , Total sales in ... 36.8% excluding the impact of foreign currency exchange rate ... same quarter of 2013. , Gross profit increased ...
(Date:3/4/2015)... Mass., March 4, 2015 GSI Group Inc. ... "GSI"),  a global leader and supplier of precision photonics ... equipment and advanced industrial technology markets, today reported financial ... Unless otherwise noted, all financial results in this press ... Fourth QuarterDuring the fourth quarter of 2014, GSI ...
(Date:3/4/2015)... -- Alimera Sciences, Inc. (NASDAQ: ALIM ... the research, development and commercialization of prescription ophthalmic ... quarter and year ended December 31, 2014. ... for Alimera Sciences, most notably having received U.S. ... treatment of diabetic macular edema," said Dan Myers, ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15
... of Disease Activity as Measured,by MRI and Relapse ... May 1, 2007 -- Genentech, Inc.,(NYSE: DNA) ... from a Phase II clinical study of Rituxan®,(rituximab) in ... the American Academy of Neurology,annual meeting held in Boston. ...
... BOSTON--(BUSINESS WIRE)--May 1, 2007 - Significantly more patients,treated ... percent or,more compared with placebo, according to study ... annual meeting.,Clinically, this outcome would equate to a ... to moderate pain., Fibromyalgia is one of the ...
Cached Medicine Technology:Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6Lyrica Significantly Reduced Pain and Helped Patients Manage the,Symptoms of Fibromyalgia, Data Show 2Lyrica Significantly Reduced Pain and Helped Patients Manage the,Symptoms of Fibromyalgia, Data Show 3
... best lens available for ... One 62 mirror. Tilted ... and laser beam astigmatism. ... used on most patients ...
Direct gonioscopy lens with magnification. The lens rests on the scleral flange creating a corneal vault and leaving the anterior chamber angle undisturbed. Three sizes available....
Lacrimal cannula blunt tip with 0.3 mm side port, straight....
West lachrymal cannula, blunt tip with inner side opening, gently curved shaft....
Medicine Products: